Aug 10, 2015

The Chinese Food and Drug Administration (CFDA) has published new guidelines covering technical review components of medical device software registration.

The guidelines (link in Chinese) cover development methods for standalone and off-the-shelf software that function either as standalone medical devices or as components of or accessories to devices.

Requirements for software updates as well as upgrades are included in the CFDA guidelines. Software description and technical information documentation requirements are explained, as well as product registration information. The guidance also includes a template for software technical data submissions.

Emergo consultants will provide further details and analysis on how these new guidelines will affect medical device software registrations in China as we learn them.

Author

  • Stewart Eisenhart

Related

China Announces Expedited Market Authorization for Innovative Medical Devices

The China Food and Drug Administration (CFDA) will launch an expedited registration process (link in Chinese) on March 1, 2014 to increase availability of innovative and cutting-edge medical devices in the country.

Read more

China: New CFDA Medical Device Registration Fees in Effect

Chinese regulators have officially increased registration and related fees for Class II and III medical devices, according to the Chinese Food and Drug Administration (CFDA) and Emergo consultants in China.

Read more

Have questions on what Emergo can do for you?

CONTACT US